# US 2017/0283415 A1 · Process for producing diazabicyclooctane derivative

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283415 A1
- Document ID: US20170283415A1
- Status: Published application
- Kind: A1
- Application number: 15/613,620
- Filed: 2017-06-05
- Published: 2017-10-05
- Earliest claimed: 2013-09-24
- Assignees: Meiji Seika Pharma Co., Ltd.
- Applicants: Meiji Seika Pharma Co., Ltd.
- Inventors: Takao ABE; Takeshi FURUUCHI; Yoshiaki SAKAMAKI; Nakako MITSUHASHI
- Web page: https://patentgrep.com/patent/US20170283415A1

## CPC

- C07D 471/08: Bridged systems
- C07D 211/60: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

A process for producing a compound represented by a Formula (III), including reacting a compound of the following formula with a compound selected from the group consisting of 1-hydroxypyrrolidine-2,5-dione, 2-hydroxy-3a,4,7,7a-tetrahydro-1H-isoindol-1,3(2H)-dione, 2-hydroxyhexahydro-1H-isoindol-1,3(2H)-dione and 4-hydroxy-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione, carrying out a carbonylation to obtain a compound of the following formula removing the NH protecting group P and treating the resultant compound with a base to produce a compound represented by the following formula wherein OBn is benzyloxy and R2 is hydrogen, ClCO— or Cl3COCO—.

## Claims

### Claim 1

A process for producing a compound represented by a Formula (III), comprising: reacting a compound represented by the following Formula (I):
with a compound selected from the group consisting of 1-hydroxypyrrolidine-2,5-dione, 2-hydroxy-3a,4,7,7a-tetrahydro-1H-isoindol-1,3(2H)-dione, 2-hydroxyhexahydro-1H-isoindol-1,3(2H)-dione and 4-hydroxy-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione, allowing a carbonylating agent selected from the group consisting of phosgene, diphosgene and triphosgene to act on the resultant compound to obtain a compound represented by the following Formula (II):
removing the protecting group P and treating the resultant compound with a base to produce a compound represented by the following Formula (III):
wherein in said Formulas (I), (II) and (III), OBn is benzyloxy; P is an NH protecting group capable of being removed with an acid; R1 is 2,5-dioxopyrrolidin-1-yl, 1,3-dioxo-3a,4,7,7a-tetrahydro-1H-isoindol-2(3H)-yl, 1,3-dioxohexahydro-1H-isoindol-2(3H)-yl or 3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl and R2 is hydrogen, ClCO— or Cl3COCO—.

### Claim 2 (depends on 1)

The process according to claim 1, wherein P is tert-butoxycarbonyl.

### Claim 3 (depends on 1)

The process according to claim 1, wherein R1 is 2,5-dioxopyrrolidin-1-yl.

### Claim 4 (depends on 1)

The process according to claim 1, wherein R1 is 1,3-dioxo-3a,4,7,7a-tetrahydro-1H-isoindol-2(3H)-yl.

### Claim 5 (depends on 1)

The process according to claim 1, wherein R1 is 1,3-dioxohexahydro-1H-isoindol-2(3H)-yl.

### Claim 6 (depends on 1)

The process according to claim 1, wherein R1 is 3,5-dioxo-4-azatricyclo[5.2.1.02,6] dec-8-en-4-yl.

### Claim 7

A process for producing a compound represented by a Formula (III), comprising: allowing a carbonylating agent selected from the group consisting of phosgene, diphosgene and triphosgene to act on a compound represented by the following Formula (II):
removing the protecting group P and treating the resultant compound with a base to produce the compound represented by the following Formula (III):
wherein in said Formulas (II) and (III), OBn is benzyloxy; P is an NH protecting group capable of being removed with an acid; R1 is 2,5-dioxopyrrolidin-1-yl, 1,3-dioxo-3a,4,7,7a-tetrahydro-1H-isoindol-2(3H)-yl, 1,3-dioxohexahydro-1H-isoindol-2(3H)-yl or 3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl and R2 is hydrogen.

### Claim 8 (depends on 7)

The process according to claim 7, wherein P is tert-butoxycarbonyl.

### Claim 9 (depends on 7)

The process according to claim 7, wherein R1 is 2,5-dioxopyrrolidin-1-yl.

### Claim 10 (depends on 7)

The process according to claim 7, wherein R1 is 1,3-dioxo-3a,4,7,7a-tetrahydro-1H-isoindol-2(3H)-yl.

### Claim 11 (depends on 7)

The process according to claim 7, wherein R1 is 1,3-dioxohexahydro-1H-isoindol-2(3H)-yl.

### Claim 12 (depends on 7)

The process according to claim 7, wherein R1 is 3,5-dioxo-4-azatricyclo[5.2.1.02,6] dec-8-en-4-yl.
